C79 Category · further specificity required Secondary malignant neoplasm of other and unspecified sites
ICD-10-CM C79 identifies “Secondary malignant neoplasm of other and unspecified sites” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
More specific codes
C79.0Secondary malignant neoplasm of kidney and renal pelvisCategory · further specificity requiredC79.1Secondary malignant neoplasm of bladder and other and unspecified urinary organsCategory · further specificity requiredC79.2Secondary malignant neoplasm of skinBillable / specificC79.3Secondary malignant neoplasm of brain and cerebral meningesCategory · further specificity requiredC79.4Secondary malignant neoplasm of other and unspecified parts of nervous systemCategory · further specificity requiredC79.5Secondary malignant neoplasm of bone and bone marrowCategory · further specificity requiredC79.6Secondary malignant neoplasm of ovaryCategory · further specificity requiredC79.7Secondary malignant neoplasm of adrenal glandCategory · further specificity requiredC79.8Secondary malignant neoplasm of other specified sitesCategory · further specificity requiredC79.9Secondary malignant neoplasm of unspecified siteBillable / specificOfficial index references
References from other codes (3)
Inclusion terms · Conditions classifiable to C00-C14, C40-C49, C69-C79
Inclusion terms · Conditions classifiable to C00-C14, C40-C49, C69-C75, C7A.098, C76-C79
Inclusion terms · Conditions classifiable to C7A.098, C76, C77-C79
History
Code history
Latest recorded change · FY2018
ChangedUnchanged
FY2018
Effective from
- Code-level rules changed
Secondary malignant neoplasm of other and unspecified sites
Category — select a more specific code
CDC/NCHS · FY2018All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | Code-level rules changed |
| FY2018 | 2017-10-01 | Code-level rules changed |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.